Moonshots with Peter Diamandis cover image

David Sinclair: The GLP-1 Side Effect No One Talks About, What AI Found in His Lab, and Reversing Blindness | Q&A EP #251

Moonshots with Peter Diamandis

00:00

Telomeres and the Hayflick Barrier

David Sinclair explains the Hayflick limit, shares OSK evidence for telomerase activation, and discusses combining reprogramming with telomerase therapy.

Play episode from 02:07
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app